Rexahn Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Rockville MD United States (2001)
Status: Acquired by Ocuphire Pharma, Inc. (2020)

Organization Overview

First Clinical Trial
2008
NCT00693056
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Mergers & Acquisitions

Historical Acquisition Tree